Key Takeaways
- Materials segment delivers breakout H1: The segment added ~₹600 cr in sales and ~₹100 cr in PBT, with PBT jumping from ₹15 cr to ₹110 cr, making it the quarter's standout performer.
- Agro margin hit masks share gains: Q2 PBT fell 15% YoY as excessive rains cut insecticide applications and input costs rose, but the six-month PBT of 18% remains strong and insecticide market share has climbed from near zero to almost 5%.
- China overcapacity overhang persists: Management sees no substantial improvement in chemical segment pricing pressure, citing Chinese overcapacity and lack of sustained consumption recovery there.
- India elevated to strategic priority: BASF Group has identified India as an "advanced country" with an expectation to grow above market, and 80% of chemical market growth over the next decade is expected from seven Asian countries including India.
- What to watch next quarter: Whether the rabi season delivers on cautious optimism given full reservoirs, any stabilization in agro margins, and any concrete updates on the differentiated steering project for the agri division.
Materials Segment: The H1 Engine
- Scale of the swing: The Materials segment contributed ~₹600 cr in additional sales and ~₹100 cr in additional PBT in H1 FY25, with both Monomers and Performance Materials divisions participating; PBT surged from ₹15 cr to ₹110 cr.
- Capacity expansion underway: Polyamide compounding capacity is being increased by 40% at both Panoli and Thane sites, serving the Performance Materials division.
- Technical center opened: A 2,000 sq meter Polyurethane Technical Development Center opened in Mumbai for customer showcase, troubleshooting, training and customized solutions across construction, industry, transportation, footwear, furniture and appliance industries.
- New business being built: An alkaline surfactants plant is under construction in Gujarat for enhanced oil recovery from mature oil wells, representing a new business line for BASF.
Agrochemicals: Margin Pressure, Volume Ambition
- Q2 margin mechanics: PBT was hit by a product mix effect and higher input costs; excessive rains in central, western and southern India led to 2-3 fewer insecticide sprays, while north and east were very dry, creating a mixed monsoon picture that hurt insecticide sales and profitability.
- Six-month context matters: Despite the September quarter weakness, the six-month PBT of 18% is considered very strong, with the June quarter having been exceptionally good, making sequential comparison misleading.
- Market share story intact: BASF has grown insecticide market share from almost zero to almost 5% since the launch of Exponus, alongside three other insecticide launches (Efficon and two others) in the last 2-3 years.
- Pipeline and rabi outlook: The innovation pipeline remains strong with portfolio enhancement planned in the rice segment in the next few years; management is cautiously optimistic about the rabi season given more than 150 reservoirs in India being well filled above average.
Gerding: "I think the team has done very well to expand the portfolio launch Innovations and as you also said you know ensure the quality of the business being very solid and healthy as we expand also our market share in the in the country."
Chemical Pricing & China Overcapacity
- Structural pressure continues: The chemical segment, especially petrochemicals, continues to face pricing pressure due to Chinese overcapacity and lack of sustained recovery in Chinese consumption; no substantial improvement is expected.
- The absorption problem: Management noted that the overcapacities built and still being built in China mean those volumes "have to end somewhere," making it very difficult to see pricing pressure improving substantially.
- No bottom called: When asked whether chemical prices have bottomed out, management declined to make predictions and reiterated that no sustained recovery is visible in China.
Gerding: "The over capacities that have been built and continue to be built in China, those capacities somehow and the volumes that are produced with those capacities have to end somewhere right so this is why it's very difficult to see that the pricing pressure especially in the chemicals segment... I don't see this really improving substantially."
India's Strategic Role in BASF's Global Ambition
- "Advanced country" designation: BASF Group has globally identified India as an advanced country, meaning an expectation to grow above market and increase manufacturing and R&D capabilities in India.
- Asia's growth concentration: 80% of chemical market growth in the next 10 years is expected to come from seven Asian countries, with India being "a very strong one."
- Long-term conviction: Management expressed conviction about the robustness of Indian consumption for the next 10-20 years, calling this "India's time."
- Differentiated steering for agro: The Agricultural Solutions division is part of BASF's new global strategy with "differentiated steering," allowing it to compete more effectively against pure-play companies like Syngenta and Bayer CropScience; how this translates for BASF India Limited is still being worked on with headquarters.
- Capex continues: Investments continue across Performance Materials, Dispersion and other divisions in India, with some interesting projects under development but too early to announce.
Gerding: "80% of the chemical market growth in the next 10 years will come from seven countries all seven countries in Asia, one of them being India a very strong one."
Financial Discipline & Capital Allocation
- Working capital funded internally: Working capital increased by ~₹450 cr vs March 2024 due to higher operations but was financed entirely through internal accruals without bank borrowing.
- Cost control delivered: Operating expenses excluding COGS were reduced by 0.2% to 11.5% despite an inflationary environment.
- Surplus cash deployment questioned: An analyst noted the business generates ~25% ROCE but surplus cash is placed with group entities at 7.5%; management explained this is short-term deployment for safety and liquidity, not long-term financing, but did not provide a specific answer on dividend policy or growth capex plans when pressed.
- Receivables target: Management aims to reduce receivables by a day or two in the December quarter.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Receivables reduction | Reduce by a day or two | December quarter |
| Polyamide capacity expansion | 40% increase at Panoli and Thane | Underway, no completion date given |
| Alkaline surfactants plant | New plant for enhanced oil recovery | Under construction, no completion date given |
| Agro portfolio enhancement | Portfolio enhancement in rice segment | "Next few years" |
| Rabi season outlook | Cautiously optimistic given reservoir levels and moisture | Rabi season |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue | ₹4,248 cr, +15% YoY (12% volume growth, 3% price increase) |
| PBT before exceptional items | ₹171 cr, -15% YoY |
| H1 FY25 revenue | ₹8,820 cr, +16% YoY (17% volume growth) |
| H1 FY25 PBT before exceptional items | ₹454 cr, +29% YoY |
| PBT margin before special items (H1 FY25) | 5.6%, improved vs same period last year |
| EPS before exceptional items (H1 FY25, not annualized) | ₹78, vs ₹60 in H1 FY24 |
| ROCE (H1 FY25, not annualized) | 14.3% |
| Return on net operating assets (H1 FY25, not annualized) | 18.6%, 4% higher than last year |
| Materials segment additional sales (Q2 FY25) | ~₹300 cr over Q2 FY24 |
| Materials segment additional PBT (H1 FY25) | ~₹100 cr over H1 FY24 |
| Agrochemicals segment PBT (H1 FY25) | ₹249 cr, vs ₹310 cr in H1 FY24 |
| Agrochemicals segment PBT margin (H1 FY25) | 18%, vs ~25% in H1 FY24 |
| Agrochemicals segment PBT margin (Q2 FY25) | 12% |
| Receivables | 63 days |
| Inventory | 60 days |
| Cash flow from operations (H1 FY25) | -₹8 cr, negative due to increased working capital |
| Operating expenses excluding COGS (H1 FY25) | 11.5% of sales, reduced by 0.2% YoY |
| Insecticide market share | ~5%, up from near zero over last few years |
| Overall agricultural market share | 7–8% |
| Automotive segment share of business | 15–20% |
| Polyamide compounding capacity expansion | +40% underway at Panoli and Thane |